Trials / Unknown
UnknownNCT05758272
Evaluation of a Workplace Smoking Cessation Program in Hong Kong (Phase VI)
Evaluation of a Workplace Smoking Cessation Program in Hong Kong: a Pragmatic Cluster Randomized Controlled Trial of Mobile Supported Simple Physical Exercise for Smoking Cessation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 646 (estimated)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This study aims to test, by a 2-arm RCT, the effectiveness of an intervention that includes mobile phone-supported simple physical exercise for smoking cessation in workplaces in Hong Kong.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mobile phone-based simple physical exercise reminder to help quit smoking | Regular messages supporting participants in practicing simple physical exercises and assist in managing cravings will be sent to participants via IM apps and scheduled in a tapering manner for 3 months (twice per week in the first month to once per week in the third month). Images and videos explaining and demonstrating the simple physical exercises will be sent to the participants via IM apps, which serves as a reminder and supporting materials for participants. The benefits of exercise in SC will be explained. The investigator will also encourage the practice of moderate/ vigorous exercises to further improve the physical activity and well-being of the participants. Various delivery formats of messages will be considered to attract participants' interest such as text, emojis, voice, image, animation, and video. The simple exercises consist of a) Zero-time exercises (ZTEx), b) handgrip exercises and c) resistance exercises. |
| BEHAVIORAL | regular text-based intervention | The control group will receive 6 regular messages via IM at twice per month within 3 months. These messages cover simple cessation advice and reminders for telephone follow-ups. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-06-30
- Completion
- 2024-12-30
- First posted
- 2023-03-07
- Last updated
- 2023-12-13
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05758272. Inclusion in this directory is not an endorsement.